JPH06256249A - Production of azulenequinone compound - Google Patents
Production of azulenequinone compoundInfo
- Publication number
- JPH06256249A JPH06256249A JP4515593A JP4515593A JPH06256249A JP H06256249 A JPH06256249 A JP H06256249A JP 4515593 A JP4515593 A JP 4515593A JP 4515593 A JP4515593 A JP 4515593A JP H06256249 A JPH06256249 A JP H06256249A
- Authority
- JP
- Japan
- Prior art keywords
- azulenequinone
- formula
- group
- compound
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/693—Unsaturated compounds containing a keto groups being part of a ring containing halogen polycyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はアズレンキノン類の製造
方法に関し、さらに詳しくは、医薬、電子写真感光体、
液晶素子、有機電導体等に有用なアズレンキノン類の新
規な製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing azulene quinones, more specifically, pharmaceuticals, electrophotographic photoreceptors,
The present invention relates to a novel method for producing azulene quinones useful for liquid crystal elements, organic conductors and the like.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】アズレ
ン類は、古くから民間で薬用とされてきたニガヨモギや
カミツレ精油の成分として知られているが、とくに、近
年アズレンキノン類は、抗炎症剤、高脂血症治療剤、抗
ガン剤等の医薬としての用途の他、電子写真感光体、液
晶素子、有機電導体等への用途も期待され、多方面より
注目されている。BACKGROUND OF THE INVENTION Azulene is known as a component of the essential oils of Artemisia or Chamomile, which have long been regarded as a medicinal product by the private sector, but in recent years, azulene quinones are especially anti-inflammatory agents. In addition to its use as a drug for treating hyperlipidemia, anticancer drug, etc., it is also expected to be used for electrophotographic photoreceptors, liquid crystal elements, organic conductors, etc., and is attracting attention from various fields.
【0003】このように有用性を増しつつあるアズレン
キノン類の合成法としては、宇田・高瀬法(Chemi
stry Letters,197(1980);ib
id.,1661(1981);ibid.,1303
(1982))、野副・松原法(Chemistry
Letters,627(1984);ibid.,6
31(1984)、スコット法(J.Am.Chem.
Soc.,106,4852(1984),ibi
d.,106,4857(1984))などが知られて
いる。As a method for synthesizing azulene quinones, which are increasing in usefulness, the Uda-Takase method (Chemi
story Letters, 197 (1980); ib
id. , 1661 (1981); ibid. , 1303
(1982)), Nozomu and Matsubara method (Chemistry)
Letters, 627 (1984); ibid. , 6
31 (1984), Scott method (J. Am. Chem.
Soc. , 106 , 4852 (1984), ibi.
d. , 106 , 4857 (1984)) and the like.
【0004】しかし、上記方法はいずれも、反応ステッ
プが多段階にわたること、反応の選択性が低いこと、収
率が低いこと等の問題点を有するものである。However, each of the above-mentioned methods has problems such as multistep reaction steps, low reaction selectivity and low yield.
【0005】そこで、これらの問題を解決し、高純度の
アズレンキノン類を簡便かつ安価に製造する方法の開発
が望まれていた。Therefore, it has been desired to develop a method for solving these problems and producing a high-purity azulenequinone easily and inexpensively.
【0006】[0006]
【課題を解決するための手段】本発明者らは、かかる実
情に鑑み鋭意検討した結果、容易に入手可能なアズレン
又はアルキル置換アズレンに、酢酸中にて、臭素を反応
させることによりブロモアズレンキノン類が得られるこ
と、さらに、該ブロモアズレンキノン類に求核試薬を反
応させることによりアズレンキノン類が得られることを
見出し、本発明を完成するに至った。Means for Solving the Problems The inventors of the present invention have made extensive studies in view of such circumstances, and as a result, readily available azulene or alkyl-substituted azulene is reacted with bromine in acetic acid to give bromoazulenequinone. The inventors have found that the compounds can be obtained, and further that azulenequinones can be obtained by reacting the bromoazulenequinones with a nucleophile, and thus completed the present invention.
【0007】すなわち、本発明は、下記一般式(5)That is, the present invention provides the following general formula (5):
【0008】[0008]
【化4】 [Chemical 4]
【0009】(式中、Rは炭素数1〜4のアルキル基を
示し、nは0〜6の数を示す。但し、1及び3位、5及
び7位のうち、それぞれ少なくとも1箇所は水素原子で
ある。)で表わされるアズレン類を、酢酸中で、臭素と
反応せしめることを特徴とする下記一般式(1)又は
(2)(In the formula, R represents an alkyl group having 1 to 4 carbon atoms, and n represents a number of 0 to 6, provided that at least one of the 1- and 3-positions, 5 and 7-positions is hydrogen. Azulene represented by the following general formula (1) or (2), characterized by reacting with bromine in acetic acid.
【0010】[0010]
【化5】 [Chemical 5]
【0011】(式中、mは1〜2の整数を示し、R、n
は前記と同義である。)で表わされるブロモアズレンキ
ノン類の製造方法を提供するものである。(In the formula, m represents an integer of 1 to 2, and R, n
Is as defined above. The present invention provides a method for producing bromoazulene quinones represented by the formula (1).
【0012】本発明は、さらに、上記ブロモアズレンキ
ノン類(1)又は(2)に求核試薬を反応せしめること
を特徴とする下記一般式(3)又は(4)The present invention further comprises reacting the bromoazulene quinones (1) or (2) with a nucleophile, represented by the following general formula (3) or (4).
【0013】[0013]
【化6】 [Chemical 6]
【0014】(式中、Nuは炭素数1〜4のアルコキシ
基若しくはアミノ基、炭素数1〜6のアルキル基、アル
キルチオ基若しくはアルキレンアミノ基、アニリノ基、
トルイジノ基、メルカプト基又は活性メチレン基を示
し、R、n、mは前記と同義である)で表わされるアズ
レンキノン類の製造方法を提供するものである。(In the formula, Nu is an alkoxy group having 1 to 4 carbon atoms or an amino group, an alkyl group having 1 to 6 carbon atoms, an alkylthio group or an alkyleneamino group, an anilino group,
The present invention provides a method for producing an azulenequinone represented by a toluidino group, a mercapto group or an active methylene group, and R, n and m have the same meanings as described above.
【0015】上記一般式(1)〜(5)中のRの具体例
としては、メチル、エチル、プロピル、イソプロピル、
ブチル、イソブチル、t−ブチル等のアルキル基が挙げ
られる。Specific examples of R in the above general formulas (1) to (5) include methyl, ethyl, propyl, isopropyl,
Examples thereof include alkyl groups such as butyl, isobutyl and t-butyl.
【0016】上記一般式(3)及び(4)中の求核試薬
によりもたらされる基Nuの具体例としては、メトキ
シ、エトキシ、プロポキシ、イソプロポキシ、ブトキ
シ、イソブトキシ、t−ブトキシ等のアルコキシ基、メ
チルアミノ、ジメチルアミノ、エチルアミノ、ジエチル
アミノ、プロピルアミノ、アニリノ、トルイジノ、ピロ
リジノ、ピペリジノ、モルホリノ等のアルキルアミノ
基、芳香族アミノ基及びアルキレンアミノ基、メチルチ
オ、エチルチオ、プロピルチオ、ブチルチオ、ペンチル
チオ、ヘキシルチオ等のアルキルチオ基、マロンニトリ
ル、マロン酸ジエチル、アセト酢酸エチル等の活性メチ
レンラジカルなどが挙げられる。Specific examples of the group Nu produced by the nucleophile in the above general formulas (3) and (4) include alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy and t-butoxy, Alkylamino groups such as methylamino, dimethylamino, ethylamino, diethylamino, propylamino, anilino, toludino, pyrrolidino, piperidino, morpholino, aromatic amino groups and alkyleneamino groups, methylthio, ethylthio, propylthio, butylthio, pentylthio, hexylthio, etc. Alkylthio groups, active methylene radicals such as malonnitrile, diethyl malonate, and ethyl acetoacetate.
【0017】本発明におけるブロモアズレンキノン類
(1)又は(2)の製造は、アズレン類(5)1当量に
対し、2〜6当量好ましくは3〜4.5当量の臭素を酢
酸中又は酢酸と水との混合溶媒中、0℃〜室温下、5分
〜5時間反応せしめることによりなされる。酢酸/水混
合溶媒中の酢酸含量は10%以上が好ましい。The bromoazulene quinones (1) or (2) according to the present invention are produced by adding 2 to 6 equivalents, preferably 3 to 4.5 equivalents of bromine in acetic acid or acetic acid to 1 equivalent of the azulene (5). The reaction is carried out in a mixed solvent of water and water at 0 ° C. to room temperature for 5 minutes to 5 hours. The acetic acid content in the acetic acid / water mixed solvent is preferably 10% or more.
【0018】かくして得られる反応液は、次に水処理す
ることが好ましい。水処理は、上記得られた反応混合物
を水中に注ぎ、析出した結晶を濾取すること又は反応混
合物を適当な有機溶媒、例えばベンゼン中に注いで抽出
することにより行う。The reaction liquid thus obtained is then preferably treated with water. The water treatment is carried out by pouring the obtained reaction mixture into water and filtering the precipitated crystals, or by pouring the reaction mixture into a suitable organic solvent such as benzene for extraction.
【0019】上記により得られた結晶若しくは抽出物
は、公知の分別再結晶、カラムクロマトグラフィー等の
手段により精製することが好ましい。これらの精製手段
により目的のブロモアズレンキノン類(1)又は(2)
を50%前後の高い収率で得ることができる。The crystals or extracts obtained as described above are preferably purified by known means such as fractional recrystallization and column chromatography. The desired bromoazulene quinones (1) or (2) are obtained by these purification means.
Can be obtained in a high yield of around 50%.
【0020】本発明のアズレンキノン類(3)又は
(4)は、上記ブロモアズレンキノン類(1)又は
(2)と求核試薬とを反応せしめることにより製造でき
る。The azulenequinones (3) or (4) of the present invention can be produced by reacting the bromoazulenequinones (1) or (2) with a nucleophile.
【0021】本発明に使用される求核試薬は、イオン反
応において、反応にあずかる試薬が相手に電子を与える
傾向を有するものであり、具体的にはナトリウムメチラ
ートなどのナトリウムアルコラート類、トルイジンなど
のアミン類、ブチルチオールなどのチオール類、マロン
ニトリルなどの活性メチレン化合物が挙げられる。The nucleophile used in the present invention is one in which the reagent participating in the reaction has a tendency to give an electron to the other party in an ionic reaction. Specifically, sodium alcoholate such as sodium methylate, toluidine, etc. And amines, thiols such as butylthiol, and active methylene compounds such as malonnitrile.
【0022】上記ブロモアズレンキノン類(1)又は
(2)と求核試薬との反応によるアズレンキノン類
(3)又は(4)の製造は、該ブロモアズレンキノン類
1当量に対し1当量以上の求核試薬を、アルコール系溶
媒中、10〜80℃にて5分〜24時間反応せしめるこ
とによりなされる。The production of azulenequinones (3) or (4) by reacting the bromoazulene quinones (1) or (2) with a nucleophile is carried out in an amount of 1 equivalent or more per 1 equivalent of the bromoazulene quinones. It is carried out by reacting a nucleophile in an alcoholic solvent at 10 to 80 ° C. for 5 minutes to 24 hours.
【0023】使用されるアルコールとしては、メタノー
ル、エタノールなどの低級アルコールが挙げられる。Examples of the alcohol used include lower alcohols such as methanol and ethanol.
【0024】得られる反応生成物は、公知の分別再結
晶、カラムクロマトグラフィー等の手段により精製する
ことが好ましい。これらの精製手段により目的のアズレ
ンキノン類(3)又は(4)を80%以上の収率で得る
ことができる。The obtained reaction product is preferably purified by a known means such as fractional recrystallization or column chromatography. By these purification means, the target azulenequinones (3) or (4) can be obtained in a yield of 80% or more.
【0025】[0025]
【発明の効果】本発明の方法によれば、医薬、電子写真
感光体、液晶素子、有機電導体等に有用な高純度のアズ
レンキノン類を簡便かつ安価に得ることができる。According to the method of the present invention, high-purity azulenequinones useful for medicines, electrophotographic photoreceptors, liquid crystal devices, organic conductors, etc. can be obtained easily and inexpensively.
【0026】[0026]
【実施例】以下に本発明を実施例により具体的に説明す
るが、本発明はこれらに限定されるものではない。EXAMPLES The present invention will be described in detail below with reference to examples, but the present invention is not limited thereto.
【0027】実施例1 3−ブロム−1,7−アズレンキノン(1a)及び3−
ブロム−1,5−アズレンキノン(2a)の製造(75
%酢酸中) 50mlナスフラスコにアズレン200mg(1.56mmo
l)を取り、40mlの酢酸に加熱溶解した。これに14m
lの蒸留水を加え、室温まで冷却した。この溶液に、酢
酸4mlに溶解した臭素840mg(5.25mmol)を室温
下に加え、20分間撹拌した。その後、この反応液を8
00mlの蒸留水に注ぎ、さらに室温で1時間撹拌した。
生成した沈澱を吸引濾過した後、濾液をベンゼン抽出
(2回)し、水洗(2回)後、硫酸マグネシウムで乾燥
した。溶媒除去後真空乾燥することにより、目的物(1
a)及び(2a)の混合物を184mg(0.78mmol)
得た(収率50%)。この混合物をシリカゲルカラムク
ロマトグラフィー(Merck Art.9385,K
iselgel 60、ベンゼン:メタノール=50:
1)により分離精製し、(1a)と(2a)を1:3の
割合で得た。Example 1 3-Brom-1,7-azulenequinone (1a) and 3-
Production of bromo-1,5-azulenequinone (2a) (75
% Acetic acid) Azulene 200 mg (1.56 mmo) in a 50 ml eggplant flask.
l) was taken and dissolved by heating in 40 ml of acetic acid. 14m to this
l of distilled water was added and cooled to room temperature. To this solution, 840 mg (5.25 mmol) of bromine dissolved in 4 ml of acetic acid was added at room temperature, and the mixture was stirred for 20 minutes. Then, add this reaction solution to 8
It was poured into 00 ml of distilled water and further stirred at room temperature for 1 hour.
After the formed precipitate was filtered by suction, the filtrate was extracted with benzene (twice), washed with water (twice), and dried over magnesium sulfate. After removing the solvent, the product (1
184 mg (0.78 mmol) of the mixture of a) and (2a)
Obtained (yield 50%). This mixture was subjected to silica gel column chromatography (Merck Art. 9385, K).
iselgel 60, benzene: methanol = 50:
Separation and purification according to 1) gave (1a) and (2a) in a ratio of 1: 3.
【0028】[0028]
【化7】 [Chemical 7]
【0029】淡黄色針状晶;mp 142℃分解 IR(KBr):3100,2920,1710,1642,1584,1522,1430,1380,12
80,1268,1172,1138,1040,997,925,850,812cm -1 1 H NMR(270MHz,CDCl3) δ:6.81(1H,s,H-2),6.91(1H,ddd,J=12.2,2.7,0.8Hz,H-
6),7.05(1H,ddd,J=8.2,0.8,0.5Hz,H-4),7.17(1H,dd,J=1
2.2,8.2Hz,H-5),7.24(1H,dd,J=2.7,0.5Hz,H-8). MS(70eV):m/z 238(M+,11%),236(M+,11%),210(15%),2
08(15%),129(100%),101(50%).Pale yellow needles; mp 142 ° C decomposition IR (KBr): 3100,2920,1710,1642,1584,1522,1430,1380,12
80,1268,1172,1138,1040,997,925,850,812cm -1 1 H NMR (270MHz, CDCl 3 ) δ: 6.81 (1H, s, H-2), 6.91 (1H, ddd, J = 12.2,2.7,0.8Hz , H-
6), 7.05 (1H, ddd, J = 8.2,0.8,0.5Hz, H-4), 7.17 (1H, dd, J = 1
2.2,8.2Hz, H-5), 7.24 (1H, dd, J = 2.7,0.5Hz, H-8) .MS (70eV): m / z 238 (M + , 11%), 236 (M + , 11%), 210 (15%), 2
08 (15%), 129 (100%), 101 (50%).
【0030】[0030]
【化8】 [Chemical 8]
【0031】淡黄色針状晶;mp 135℃分解 IR(KBr):3080,3040,3000,1700,1640,1623,1585,1564,15
32,1430,1290,1233,1178,1013,905,872,849,816,624,59
5cm-1 1 H NMR(270MHz,CDCl3) δ:6.87(1H,d,J=0.7Hz,H-2),7.02(1H,ddd,J=12.1,2.4,
1.5Hz,H-6),7.11(1H,dt,J=2.4,0.7Hz,H-4),7.17(1H,dd,
J=12.1,8.0Hz,H-7),7.31(1H,ddd,J=8.0,1.5,0.7Hz,H-
8).13 C NMR(67.8MHz,CDCl3)δ:127.522(d),133.585(d),13
4.460(d),134.460(s),136.471(d),144.045(d),144.272
(s),152.705(s),186.276(s),189.665(s). MS(70eV):m/z 238(M+,10%),236(M+,10%),210(15%),2
08(15%),129(100%). 測定値:C,50.56;H,2.23;N,0.00%. 計算値:(C10H5Br2):C,50.67;H,2.13;N,0.00%.Pale yellow needles; mp 135 ° C decomposition IR (KBr): 3080,3040,3000,1700,1640,1623,1585,1564,15
32,1430,1290,1233,1178,1013,905,872,849,816,624,59
5 cm -1 1 H NMR (270 MHz, CDCl 3 ) δ: 6.87 (1H, d, J = 0.7Hz, H-2), 7.02 (1H, ddd, J = 12.1,2.4,
1.5Hz, H-6), 7.11 (1H, dt, J = 2.4,0.7Hz, H-4), 7.17 (1H, dd,
J = 12.1,8.0Hz, H-7), 7.31 (1H, ddd, J = 8.0,1.5,0.7Hz, H-
8). 13 C NMR (67.8 MHz, CDCl 3 ) δ: 127.522 (d), 133.585 (d), 13
4.460 (d), 134.460 (s), 136.471 (d), 144.045 (d), 144.272
(s), 152.705 (s), 186.276 (s), 189.665 (s) .MS (70eV): m / z 238 (M + , 10%), 236 (M + , 10%), 210 (15%) , 2
. 08 (15%), 129 (100%) measurements:. C, 50.56; H, 2.23; N, 0.00% Calculated: (C 10 H 5 Br 2 ): C, 50.67; H, 2.13; N, 0.00%.
【0032】実施例2 3−ブロム−1,7−アズレンキノン(1a)及び3−
ブロム−1,5−アズレンキノン(2a)の製造(67
%酢酸中) 50mlナスフラスコにアズレン200mg(1.56mmo
l)を取り、40mlの酢酸に加熱溶解した。これに20m
lの蒸留水を加え、室温まで冷却した。この溶液に、酢
酸4mlに溶解した臭素840mg(5.25mmol)を室温
下に加え、20分間撹拌した。その後、この反応液を実
施例1と同様に処理して目的の(1a)及び(2a)の
混合物を160mg(0.68mmol)得た(収率43
%)。Example 2 3-Brom-1,7-azulenequinone (1a) and 3-
Production of Brom-1,5-azulenequinone (2a) (67
% Acetic acid) Azulene 200 mg (1.56 mmo) in a 50 ml eggplant flask.
l) was taken and dissolved by heating in 40 ml of acetic acid. 20m to this
l of distilled water was added and cooled to room temperature. To this solution, 840 mg (5.25 mmol) of bromine dissolved in 4 ml of acetic acid was added at room temperature, and the mixture was stirred for 20 minutes. Then, this reaction solution was treated in the same manner as in Example 1 to obtain 160 mg (0.68 mmol) of the desired mixture of (1a) and (2a) (yield 43.
%).
【0033】実施例3 3−ブロム−1,7−アズレンキノン(1a)及び3−
ブロム−1,5−アズレンキノン(2a)の製造(85
%酢酸中の反応) 50mlナスフラスコにアズレン200mg(1.56mmo
l)を取り、40mlの酢酸に加熱溶解した。これに8ml
の蒸留水を加え、室温まで冷却した。この溶液に、酢酸
4mlに溶解した臭素840mg(5.25mmol)を室温下
に加え、20分間撹拌した。その後、この反応液を実施
例1と同様に処理し、目的の(1a)及び(2a)の混
合物を144mg(0.61mmol)得た(収率39%)。Example 3 3-Brom-1,7-azulenequinone (1a) and 3-
Production of Brom-1,5-azulenequinone (2a) (85
% Reaction in acetic acid) Azulene 200 mg (1.56 mmo) in a 50 ml eggplant flask.
l) was taken and dissolved by heating in 40 ml of acetic acid. 8 ml to this
Of distilled water was added, and the mixture was cooled to room temperature. To this solution, 840 mg (5.25 mmol) of bromine dissolved in 4 ml of acetic acid was added at room temperature, and the mixture was stirred for 20 minutes. Then, this reaction solution was treated in the same manner as in Example 1 to obtain 144 mg (0.61 mmol) of the desired mixture of (1a) and (2a) (yield 39%).
【0034】実施例4 3−ブロム−1,7−アズレンキノン(1a)及び3−
ブロム−1,5−アズレンキノン(2a)の製造(98
%酢酸中の反応) 50mlナスフラスコにアズレン200mg(1.56mmo
l)を取り、40mlの酢酸に加熱溶解し、室温まで冷却
した。この溶液に、酢酸4mlに溶解した臭素800mg
(5.00mmol)を室温下加え、10分間撹拌した。そ
の後、この反応液を実施例1と同様に処理し、目的の
(1a)及び(2a)の混合物を140mg(0.59mm
ol)得た(収率38%)。Example 4 3-Brom-1,7-azulenequinone (1a) and 3-
Production of bromo-1,5-azulenequinone (2a) (98
% Reaction in acetic acid) Azulene 200 mg (1.56 mmo) in a 50 ml eggplant flask.
l) was taken, dissolved by heating in 40 ml of acetic acid, and cooled to room temperature. 800 mg of bromine dissolved in 4 ml of acetic acid
(5.00 mmol) was added at room temperature and stirred for 10 minutes. Thereafter, this reaction solution was treated in the same manner as in Example 1 to obtain 140 mg (0.59 mm) of the desired mixture of (1a) and (2a).
ol) was obtained (yield 38%).
【0035】実施例5 3,5−ジブロム−1,7−アズレンキノン(1b)及
び3,7−ジブロム−1,5−アズレンキノン(2b)
の製造 50mlナスフラスコにアズレン200mg(1.56mmo
l)を取り、40mlの酢酸に加熱溶解し、室温まで冷却
した。この溶液に酢酸4mlに溶解した臭素1.1g
(6.88mmol)を室温下に加え、10分間撹拌した。
その後、この反応液を800mlの蒸留水に注ぎ、さらに
室温で1時間撹拌した。生成した沈澱を吸引濾過後、濾
液をベンゼンで抽出(2回)し、水洗(2回)後、硫酸
マグネシウムで乾燥した。溶媒除去後真空乾燥すること
により、150mgの(1a)、(2a)及び(1b)、
(2b)の混合物をそれぞれ得た。この混合物はシリカ
ゲルカラムクロマトグラフィー(Merck Art.
9385,Kiselgel 60、ベンゼン:メタノ
ール=50:1)により分離精製し、目的の(1b)及
び(2b)の混合物を得た〔収率:15%、(1b)と
(2b)との割合は1:3〕。Example 5 3,5-dibromo-1,7-azulenequinone (1b) and 3,7-dibromo-1,5-azulenequinone (2b)
200 mg of azulene (1.56 mmo in a 50 ml eggplant flask)
l) was taken, dissolved by heating in 40 ml of acetic acid, and cooled to room temperature. 1.1 g of bromine dissolved in 4 ml of acetic acid
(6.88 mmol) was added at room temperature and stirred for 10 minutes.
Then, the reaction solution was poured into 800 ml of distilled water and further stirred at room temperature for 1 hour. The formed precipitate was filtered by suction, the filtrate was extracted with benzene (twice), washed with water (twice), and dried over magnesium sulfate. After removing the solvent, vacuum drying was performed to obtain 150 mg of (1a), (2a) and (1b),
The respective mixtures of (2b) were obtained. This mixture was subjected to silica gel column chromatography (Merck Art.
9385, Kiselgel 60, benzene: methanol = 50: 1) to separate and purify to obtain the desired mixture of (1b) and (2b) [yield: 15%, the ratio of (1b) and (2b): 1: 3].
【0036】[0036]
【化9】 [Chemical 9]
【0037】淡黄色針状晶;mp 153℃分解 IR(KBr):3100,2920,2850,1705,1636,1590,1524,1401,13
68,1296,1253,1239,1192,1037,910,902,853,811,739,61
2cm-1 1 H NMR(270MHz,CDCl3) δ:6.88(1H,s,H-2),7.19(1H,dd,J=2.6,0.7Hz,H-4),7.25
(1H,dd,J=2.3,0.7Hz,H-8),7.42(1H,dd,J=2.6,2.3Hz,H-
6). MS(70eV):m/z 318(M+,3%),316(M +,5%),314(M+,3%),
290(20%),288(40%),286(21%),209(96%),207(100
%). 実測値:M+,313.8540,315.8586,and 317.8555(1:2:1). 計算値:(C10H4OBr):M,313.8578,315.8559,317.8539.Light yellow needle crystals; mp 153 ° C decomposition IR (KBr): 3100,2920,2850,1705,1636,1590,1524,1401,13
68,1296,1253,1239,1192,1037,910,902,853,811,739,61
2 cm -1 1 H NMR (270 MHz, CDCl 3 ) δ: 6.88 (1H, s, H-2), 7.19 (1H, dd, J = 2.6,0.7Hz, H-4), 7.25
(1H, dd, J = 2.3,0.7Hz, H-8), 7.42 (1H, dd, J = 2.6,2.3Hz, H-
6) .MS (70eV): m / z 318 (M + , 3%), 316 (M + , 5%), 314 (M + , 3%),
290 (20%), 288 (40%), 286 (21%), 209 (96%), 207 (100
Measured: M + , 313.8540,315.8586, and 317.8555 (1: 2: 1). Calculated: (C 10 H 4 OBr): M, 313.8578,315.8559,317.8539.
【0038】[0038]
【化10】 [Chemical 10]
【0039】淡黄色針状晶;mp 138℃分解 IR(KBr):3090,2920,2850,1706,1635,1584,1530,1400,13
70,1300,1282,1250,1218,1190,1050,908,880,850,757,6
34,615cm-1 1 H NMR(270MHz,CDCl3) δ:6.89(1H,d,J=0.6Hz,H-2),7.06(1H,ddd,J=2.1,0.8,0.
6Hz,H-4),7.48(1H,dd,J=2.3,0.8Hz,H-8),7.50(1H,dd,J=
2.3,2.1Hz,H-6). MS(70eV):m/z 318(M+,5%),316(M +,10%),314(M+,6
%),290(17%),288(33%),286(18%),209(100%),207(1
00%). 実測値:M+,313.8540,315.8586,317.8555(1:2:1). 計算値:(C10H4OBr):M,313.8578,315.8559,317.8539.Pale yellow needle crystals; mp 138 ° C decomposition IR (KBr): 3090,2920,2850,1706,1635,1584,1530,1400,13
70,1300,1282,1250,1218,1190,1050,908,880,850,757,6
34,615 cm -1 1 H NMR (270MHz, CDCl 3 ) δ: 6.89 (1H, d, J = 0.6Hz, H-2), 7.06 (1H, ddd, J = 2.1,0.8,0.
6Hz, H-4), 7.48 (1H, dd, J = 2.3,0.8Hz, H-8), 7.50 (1H, dd, J =
2.3,2.1Hz, H-6) .MS (70eV): m / z 318 (M + , 5%), 316 (M + , 10%), 314 (M + , 6)
%), 290 (17%), 288 (33%), 286 (18%), 209 (100%), 207 (1
Measured value: M + , 313.8540,315.8586,317.8555 (1: 2: 1). Calculated value: (C 10 H 4 OBr): M, 313.8578,315.8559,317.8539.
【0040】実施例6 3−(p−トルイジノ)−1,7−アズレンキノン(3
a)の製造 20mlナスフラスコに3−ブロム−1,7−アズレンキ
ノン(1a)140mg(0.59mmol)を取り、20ml
のメタノールに加熱溶解し、室温まで冷却した。この溶
液に、メタノール2mlに溶解したp−トルイジン90mg
(0.84mmol)を室温下に加え、撹拌した。反応1時
間後、生成した沈澱を濾過し、母液はシリカゲルカラム
クロマトグラフィー(ベンゼン:メタノール=50:
1)により分離精製し、(3a)を得た(収率95
%)。Example 6 3- (p-toluidino) -1,7-azulenequinone (3
Preparation of a) 140 mg (0.59 mmol) of 3-bromo-1,7-azulenequinone (1a) was placed in a 20 ml eggplant flask and added to 20 ml.
Was dissolved in methanol by heating and cooled to room temperature. 90 mg of p-toluidine dissolved in 2 ml of methanol was added to this solution.
(0.84 mmol) was added at room temperature and stirred. After 1 hour of reaction, the formed precipitate was filtered and the mother liquor was subjected to silica gel column chromatography (benzene: methanol = 50:
Separation and purification according to 1) yielded (3a) (yield 95
%).
【0041】[0041]
【化11】 [Chemical 11]
【0042】黄色プリズム状晶;mp 282℃分解 IR(KBr):3240,2920,1668,1638,1590,1542,1508,1408,11
95,817,615cm-1 1 H NMR(270MHz,DMSO-d6) δ:2.23(3H,s,CH3),5.79(1H,s,H-2),6.85(1H,dd,J=11.
9,2.8Hz,H-6),6.88(1H,d,J=2.8Hz,H-8),7.28(4H,m,H-
2',3',5',6'),7.35(1H,dd,J=11.9,8.4Hz,H-5),7.61(1H,
d,J=8.4Hz,H-4),10.15(1H,br,NH). MS(70eV):m/z 263(M+,57%),235(94%),234(57%),207
(100%),206(92%). 実測値:C,77.49;H,5.26;N,4.99%. 計算値:(C17H13NO2):C,77.55;H,4.98;N,5.32%.Yellow prismatic crystals; mp 282 ° C decomposition IR (KBr): 3240,2920,1668,1638,1590,1542,1508,1408,11
95,817,615 cm -1 1 H NMR (270MHz, DMSO-d 6 ) δ: 2.23 (3H, s, CH 3 ), 5.79 (1H, s, H-2), 6.85 (1H, dd, J = 11.
9,2.8Hz, H-6), 6.88 (1H, d, J = 2.8Hz, H-8), 7.28 (4H, m, H-
2 ', 3', 5 ', 6'), 7.35 (1H, dd, J = 11.9,8.4Hz, H-5), 7.61 (1H,
d, J = 8.4Hz, H-4), 10.15 (1H, br, NH) .MS (70eV): m / z 263 (M + , 57%), 235 (94%), 234 (57%), 207
(100%), 206 (92%). Actual value: C, 77.49; H, 5.26; N, 4.99% .Calculated value: (C 17 H 13 NO 2 ): C, 77.55; H, 4.98; N, 5.32 %.
【0043】実施例7 3−(p−トルイジノ)−1,5−アズレンキノン(4
a)の製造 実施例6と同様に、3−ブロム−1,5−アズレンキノ
ン(1a)とp−トルイジンとの反応により(4a)を
得た(収率94%)。Example 7 3- (p-toluidino) -1,5-azulenequinone (4
Production of a) In the same manner as in Example 6, 3-brom-1,5-azulenequinone (1a) was reacted with p-toluidine to obtain (4a) (yield 94%).
【0044】[0044]
【化12】 [Chemical 12]
【0045】黄色プリズム状晶;mp 290℃分解 IR(KBr):3240,3020,1664,1640,1592,1580,1545,1510,13
95,1238,1190,911,803cm-1 1 H NMR(270MHz,DMSO-d6) δ:2.22(3H,s,CH3),5.82(1H,s,H-2),6.88(1H,ddd,J=11.
6,2.6,0.8Hz,H-6),7.17(1H,dd,J=7.8,0.8Hz,H-8),7.28
(4H,m,H-2',3',5',6'),7.33(1H,dd,J=11.6,7.8Hz,H-7),
7.57(1H,d,J=2.6Hz,H-4),9.81(1H,br,NH). MS(70eV):m/z 263(M+,87%),246(37%),234(100%),207
(51%),206(77%). 実測値:C,77.46;H,5.29;N,5.08%. 計算値:(C17H13NO2):C,77.55;H,4.98;N,5.32%.Yellow prismatic crystals; mp 290 ° C decomposition IR (KBr): 3240,3020,1664,1640,1592,1580,1545,1510,13
95,1238,1190,911,803cm -1 1 H NMR (270MHz, DMSO-d 6 ) δ: 2.22 (3H, s, CH 3 ), 5.82 (1H, s, H-2), 6.88 (1H, ddd, J = 11.
6,2.6,0.8Hz, H-6), 7.17 (1H, dd, J = 7.8,0.8Hz, H-8), 7.28
(4H, m, H-2 ', 3', 5 ', 6'), 7.33 (1H, dd, J = 11.6,7.8Hz, H-7),
7.57 (1H, d, J = 2.6Hz, H-4), 9.81 (1H, br, NH) .MS (70eV): m / z 263 (M + , 87%), 246 (37%), 234 ( 100%), 207
(51%), 206 (77%). Actual value: C, 77.46; H, 5.29; N, 5.08% .Calculated value: (C 17 H 13 NO 2 ): C, 77.55; H, 4.98; N, 5.32 %.
【0046】実施例8 3−ブチルアミノ−1,7−アズレンキノン(3b)及
び3−ブチルアミノ−1,5−アズレンキノン(4b)
の製造 20mlフラスコに(1a)及び(1b)の混合物(混合
比;1:3)を110mg(0.46mmol)秤取し、10
mlのメタノールと5mlのクロロホルム混合液に加熱溶解
し、室温まで冷却した。この溶液に、メタノール1mlに
溶解したn−ブチルアミン70mg(0.96mmol)を室
温下で加え、撹拌した。反応30分後、溶媒を除去し、
残渣はシリカゲルカラムクロマトグラフィー(ベンゼ
ン:メタノール=50:1)により分離精製し、(3
b)(23mg、収率86%)及び(4b)(65mg、収
率82%)を得た。Example 8 3-Butylamino-1,7-azulenequinone (3b) and 3-butylamino-1,5-azulenequinone (4b)
Preparation of 110 mg (0.46 mmol) of a mixture of (1a) and (1b) (mixing ratio; 1: 3) was weighed in a 20 ml flask and 10
It was dissolved by heating in a mixed solution of methanol (5 ml) and chloroform (5 ml) and cooled to room temperature. To this solution, 70 mg (0.96 mmol) of n-butylamine dissolved in 1 ml of methanol was added at room temperature and stirred. After 30 minutes of reaction, the solvent was removed,
The residue was separated and purified by silica gel column chromatography (benzene: methanol = 50: 1), and
b) (23 mg, yield 86%) and (4b) (65 mg, yield 82%) were obtained.
【0047】[0047]
【化13】 [Chemical 13]
【0048】黄色針状晶;mp 178-180℃ IR(KBr):3240,2950,2920,2850,1665,1641,1610-1550,14
60,1376,1250,1212,1110,1035,995,905,855,795,645cm
-1 1 H NMR(270MHz,CDCl3) δ:0.99(3H,t,J=7.3Hz,CH3),1.46(2H,m,CH2),1.72(2H,
m,CH2),3.38(2H,m,NCH2),5.56(1H,s,H-2),5.61(1H,br,N
H),6.72(1H,dd,J=8.1,0.8Hz,H-4),6.89(1H,ddd,J=12.2,
2.7,0.8Hz,H-6),7.05(1H,dd,J=12.2,8.1Hz,H-5),7.26(1
H,d,J=2.7Hz,H-8). MS(70eV):m/z 229(M+,43%),186(15%),159(100%),158
(25%),145(30%),130(48%). 実測値:M+,229.1091. 計算値:(C14H15NO2):M,229.1102.Yellow needles; mp 178-180 ° C IR (KBr): 3240,2950,2920,2850,1665,1641,1610-1550,14
60,1376,1250,1212,1110,1035,995,905,855,795,645cm
-1 1 H NMR (270MHz, CDCl 3 ) δ: 0.99 (3H, t, J = 7.3Hz, CH 3 ), 1.46 (2H, m, CH 2 ), 1.72 (2H,
m, CH 2 ), 3.38 (2H, m, NCH 2 ), 5.56 (1H, s, H-2), 5.61 (1H, br, N
H), 6.72 (1H, dd, J = 8.1,0.8Hz, H-4), 6.89 (1H, ddd, J = 12.2,
2.7,0.8Hz, H-6), 7.05 (1H, dd, J = 12.2,8.1Hz, H-5), 7.26 (1
H, d, J = 2.7Hz, H-8) .MS (70eV): m / z 229 (M + , 43%), 186 (15%), 159 (100%), 158
(25%), 145 (30%), 130 (48%). Actual value: M + , 229.1091. Calculated value: (C 14 H 15 NO 2 ): M, 229.1102.
【0049】[0049]
【化14】 [Chemical 14]
【0050】黄色プリズム状晶;mp 202-204℃ IR(KBr):3250,2950,2925,2860,1665,1640,1600-1500,14
60,1438,1370,1235,1190,1105,915,855,792,628cm-1 1 H NMR(270MHz,CDCl3) δ:0.98(3H,t,J=7.3Hz,CH3),1.46(2H,m,CH2),1.78(2H,
m,CH2),3.44(2H,m,NCH2),5.59(1H,s,H-2),5.82(1H,br,N
H),6.92(1H,dt,J=11.1,2.3Hz,H-6),7.25(1H,dd,J=11.1,
8.3Hz,H-7),7.29(1H,dd,J=8.3,2.3Hz,H-8),7.47(1H,d,J
=2.3Hz,H-4).13 C NMR(67.8MHz,CDCl3)δ:13.736(q,CH3),20.159(t,CH
2),30.522(t,CH2),45.393(t,CH2),101.830(d),124.568
(d),127.341(d),137.428(d),141.142(d),141.369(s),14
3.315(s),164.966(s),187.768(s),188.043(s). MS(70eV):m/z 229(M+,45%),186(23%),159(100%),158
(31%),130(58%). 実測値:M+,229.1091. 計算値:(C14H15NO2):M,229.1102.Yellow prism-like crystals; mp 202-204 ° C IR (KBr): 3250,2950,2925,2860,1665,1640,1600-1500,14
60,1438,1370,1235,1190,1105,915,855,792,628cm -1 1 H NMR (270MHz, CDCl 3 ) δ: 0.98 (3H, t, J = 7.3Hz, CH 3 ), 1.46 (2H, m, CH 2 ), 1.78 (2H,
m, CH 2 ), 3.44 (2H, m, NCH 2 ), 5.59 (1H, s, H-2), 5.82 (1H, br, N
H), 6.92 (1H, dt, J = 11.1,2.3Hz, H-6), 7.25 (1H, dd, J = 11.1,
8.3Hz, H-7), 7.29 (1H, dd, J = 8.3,2.3Hz, H-8), 7.47 (1H, d, J
= 2.3Hz, H-4). 13 C NMR (67.8MHz, CDCl 3 ) δ: 13.736 (q, CH 3 ), 20.159 (t, CH
2 ), 30.522 (t, CH 2 ), 45.393 (t, CH 2 ), 101.830 (d), 124.568
(d), 127.341 (d), 137.428 (d), 141.142 (d), 141.369 (s), 14
3.315 (s), 164.966 (s), 187.768 (s), 188.043 (s) .MS (70eV): m / z 229 (M + , 45%), 186 (23%), 159 (100%), 158
(31%), 130 (58%). Actual value: M + , 229.1091. Calculated value: (C 14 H 15 NO 2 ): M, 229.1102.
【0051】実施例9 3−メトキシ−1,7−アズレンキノン(3c)及び3
−メトキシ−1,5−アズレンキノン(4c)の製造 50mlナスフラスコに(1a)と(2a)の混合物
(1:3)を150mg(0.63mmol)秤取し、20ml
の乾燥メタノールに加熱溶解し、室温まで冷却した。こ
の溶液に、メタノール1mlに溶解したナトリウムメチラ
ート70mg(1.30mmol)を室温下に加え、撹拌し
た。反応20分後原料が消失したので、これに飽和食塩
水を加えベンゼン抽出(2回)し、水洗(2回)後、硫
酸マグネシウムで乾燥した。抽出液は、溶媒を除去し、
残渣はシリカゲルカラムクロマトグラフィー(ベンゼ
ン:メタノール=50:1)により分離精製し、(3
c)(20mg、収率67%)及び(4c)(55mg、収
率62%)を得た。Example 9 3-Methoxy-1,7-azulenequinone (3c) and 3
Preparation of -methoxy-1,5-azulenequinone (4c) In a 50 ml round-bottomed flask, 150 mg (0.63 mmol) of the mixture (1: 3) of (1a) and (2a) was weighed and added to 20 ml.
Was dissolved in dry methanol by heating and cooled to room temperature. To this solution, 70 mg (1.30 mmol) of sodium methylate dissolved in 1 ml of methanol was added at room temperature and stirred. After 20 minutes from the reaction, the raw material disappeared, so saturated saline was added thereto, and the mixture was extracted with benzene (twice), washed with water (twice), and dried over magnesium sulfate. The extraction liquid removes the solvent,
The residue was separated and purified by silica gel column chromatography (benzene: methanol = 50: 1), and
c) (20 mg, 67% yield) and (4c) (55 mg, 62% yield) were obtained.
【0052】[0052]
【化15】 [Chemical 15]
【0053】淡黄色針状晶;mp 207℃ IR(KBr):3080,3020,2940,1705,1640,1600-1530,1440,13
50,1250,1230,1185,1095,1039,945,850,832,820,764,73
0,645cm-1 1 H NMR(270MHz,CDCl3) δ:4.07(3H,s,OCH3),5.72(1H,s,H-2),6.89(1H,ddd,J=1
1.9,2.5,1.3Hz,H-6),7.00(1H,ddd,J=8.0,1.3,0.7Hz,H-
4),7.09(1H,dd,J=11.9,8.0Hz,H-5),7.27(1H,dd,J=2.5,
0.7Hz,H-8).13 C NMR(67.8MHz,CDCl3)δ:59.308(q),104.328(d),122.
784(d),132.498(d),135.028(d),138.774(s),139.131
(s),141.288(d),141.466(s),187.850(s),190.087(s). MS(70eV):m/z 188(M+)Pale yellow needles; mp 207 ° C IR (KBr): 3080,3020,2940,1705,1640,1600-1530,1440,13
50,1250,1230,1185,1095,1039,945,850,832,820,764,73
0,645cm -1 1 H NMR (270MHz, CDCl 3 ) δ: 4.07 (3H, s, OCH 3 ), 5.72 (1H, s, H-2), 6.89 (1H, ddd, J = 1
1.9,2.5,1.3Hz, H-6), 7.00 (1H, ddd, J = 8.0,1.3,0.7Hz, H-
4), 7.09 (1H, dd, J = 11.9,8.0Hz, H-5), 7.27 (1H, dd, J = 2.5,
0.7 Hz, H-8). 13 C NMR (67.8 MHz, CDCl 3 ) δ: 59.308 (q), 104.328 (d), 122.
784 (d), 132.498 (d), 135.028 (d), 138.774 (s), 139.131
(s), 141.288 (d), 141.466 (s), 187.850 (s), 190.087 (s) .MS (70eV): m / z 188 (M + )
【0054】[0054]
【化16】 [Chemical 16]
【0055】淡黄色針状晶;mp 215℃ IR(KBr):3060,2950,2920,2850,1700,1640,1610-1540,14
32,1350,1255,1235,1188,1085,1035,940,912,850,820,8
00,715cm-1 1 H NMR(270MHz,CDCl3) δ:4.06(3H,s,OCH3),5.73(1H,d,J=0.8Hz,H-2),6.95(1H,
ddd,J=12.1,2.6,1.1Hz,H-6),7.06(1H,dt,J=2.6,0.8Hz,H
-4),7.14(1H,dd,J=12.1,7.8Hz,H-7),7.29(1H,ddd,J=7.
8,1.1,0.8Hz,H-8).13 C NMR(67.8MHz,CDCl3)δ:59.292(q),105.447(d),106.
355(s),126.627(d),129.206(d),135.125(d),137.623
(s),141.510(s),143.202(s),187.005(s),189.681(s). MS(70eV):m/z 188(M+,31%),159(28%),102(100%).Pale yellow needles; mp 215 ° C IR (KBr): 3060,2950,2920,2850,1700,1640,1610-1540,14
32,1350,1255,1235,1188,1085,1035,940,912,850,820,8
00,715cm -1 1 H NMR (270MHz, CDCl 3 ) δ: 4.06 (3H, s, OCH 3 ), 5.73 (1H, d, J = 0.8Hz, H-2), 6.95 (1H,
ddd, J = 12.1,2.6,1.1Hz, H-6), 7.06 (1H, dt, J = 2.6,0.8Hz, H
-4), 7.14 (1H, dd, J = 12.1,7.8Hz, H-7), 7.29 (1H, ddd, J = 7.
8, 1.1, 0.8 Hz, H-8). 13 C NMR (67.8 MHz, CDCl 3 ) δ: 59.292 (q), 105.447 (d), 106.
355 (s), 126.627 (d), 129.206 (d), 135.125 (d), 137.623
(s), 141.510 (s), 143.202 (s), 187.005 (s), 189.681 (s) .MS (70eV): m / z 188 (M + , 31%), 159 (28%), 102 (100 %).
【0056】実施例10 3−ブチルチオ−1,7−アズレンキノン(3d)及び
3−ブチルチオ−1,5−アズレンキノン(4d)の製
造 50mlナスフラスコに(1a)及び(2a)の混合物
(割合は1:3)を90mg(0.38mmol)秤取し、1
5mlの乾燥メタノールに加熱溶解し、室温まで冷却し
た。この溶液にn−ブチルチオール200mg(2.22
mmol)を室温下に加え、撹拌した。反応3時間後、これ
に飽和食塩水を加えベンゼン抽出(2回)し、これを2
N−NaOHで2回洗浄し、水洗(2回)後、硫酸マグ
ネシウムで乾燥した。抽出液は、溶媒を除去し、残渣は
シリカゲルカラムクロマトグラフィー(ベンゼン:メタ
ノール=50:1)により分離精製し、(3d)(16
mg、収率69%)及び(4d)(42mg、収率60%)
を得た。Example 10 Preparation of 3-butylthio-1,7-azulenequinone (3d) and 3-butylthio-1,5-azulenequinone (4d) A mixture of (1a) and (2a) (ratio) in a 50 ml round-bottomed flask. Weigh 90 mg (0.38 mmol) of 1: 3), and
It was dissolved by heating in 5 ml of dry methanol and cooled to room temperature. 200 mg (2.22) of n-butylthiol was added to this solution.
mmol) was added at room temperature and stirred. After 3 hours of reaction, saturated saline was added to this, and benzene extraction (twice) was performed.
It was washed twice with N-NaOH, washed with water (twice), and dried over magnesium sulfate. The solvent was removed from the extract, and the residue was separated and purified by silica gel column chromatography (benzene: methanol = 50: 1) (3d) (16
mg, yield 69%) and (4d) (42 mg, yield 60%)
Got
【0057】[0057]
【化17】 [Chemical 17]
【0058】黄色結晶;mp 68-70℃1 H NMR(270MHz,CDCl3) δ:1.00(3H,t,J=7.3Hz,CH3),1.52(2H,m,CH2),1.80(2H,
m,CH2),3.08(2H,t,J=7.3Hz SCH2),6.33(1H,s,H-2),6.89
(1H,dd,J=8.0,0.8Hz,H-4),6.90(1H,ddd,J=12.4,2.8,0.8
Hz,H-6),7.10(1H,dd,J=12.4,8.0Hz,H-5),7.28(1H,d,J=
2.8Hz,H-8). MS(70eV):m/z 246(M+,27%),218(7%),162(100%).Yellow crystal; mp 68-70 ° C. 1 H NMR (270 MHz, CDCl 3 ) δ: 1.00 (3 H, t, J = 7.3 Hz, CH 3 ), 1.52 (2 H, m, CH 2 ), 1.80 (2 H ,
m, CH 2 ), 3.08 (2H, t, J = 7.3Hz SCH 2 ), 6.33 (1H, s, H-2), 6.89
(1H, dd, J = 8.0,0.8Hz, H-4), 6.90 (1H, ddd, J = 12.4,2.8,0.8
Hz, H-6), 7.10 (1H, dd, J = 12.4,8.0Hz, H-5), 7.28 (1H, d, J =
2.8Hz, H-8) .MS (70eV): m / z 246 (M + , 27%), 218 (7%), 162 (100%).
【0059】[0059]
【化18】 [Chemical 18]
【0060】黄色結晶;mp 135-138℃1 H NMR(270MHz,CDCl3) δ:0.99(3H,t,J=7.3Hz,CH3),1.52(2H,m,CH2),1.80(2H,
m,CH2),3.07(2H,t,J=7.3Hz SCH2),6.36(1H,s,H-2),6.96
(1H,ddd,J=11.8,2.4,1.2Hz,H-6),6.98(1H,dd,J=2.4Hz,H
-4),7.15(1H,dd,J=11.8,7.9Hz,H-7),7.26(1H,dd,J=7.9,
1.2Hz,H-8).13 C NMR(67.8MHz,CDCl3)δ:13.514(q),22.058(t),29.97
9(t),32.564(t),96.153(s),1025.307(d),126.481(d),13
0.496(d),135.025(d),137.060(s),143.075(d),145.348
(s),186.842(s),189.079(s). MS(70eV):m/z 246(M+,24%),218(10%),162(100%).Yellow crystal; mp 135-138 ° C. 1 H NMR (270 MHz, CDCl 3 ) δ: 0.99 (3H, t, J = 7.3Hz, CH 3 ), 1.52 (2H, m, CH 2 ), 1.80 (2H ,
m, CH 2 ), 3.07 (2H, t, J = 7.3Hz SCH 2 ), 6.36 (1H, s, H-2), 6.96
(1H, dd, J = 11.8,2.4,1.2Hz, H-6), 6.98 (1H, dd, J = 2.4Hz, H
-4), 7.15 (1H, dd, J = 11.8,7.9Hz, H-7), 7.26 (1H, dd, J = 7.9,
1.2 Hz, H-8). 13 C NMR (67.8 MHz, CDCl 3 ) δ: 13.514 (q), 22.058 (t), 29.97
9 (t), 32.564 (t), 96.153 (s), 1025.307 (d), 126.481 (d), 13
0.496 (d), 135.025 (d), 137.060 (s), 143.075 (d), 145.348
(s), 186.842 (s), 189.079 (s) .MS (70eV): m / z 246 (M + , 24%), 218 (10%), 162 (100%).
【0061】実施例11 3−ブロム−4,6,8−トリメチル−1,7−アズレ
ンキノン(3e)及び3−ブロム−4,6,8−トリメ
チル−1,5−アズレンキノン(4e)の製造50mlナ
スフラスコに4,6,8−トリメチルアズレン200mg
(1.18mmol)を取り、40mlの酢酸に加熱溶解し
た。これに14mlの蒸留水を加え、室温まで冷却した。
この溶液に、酢酸4mlに溶解した臭素600mg(3.7
5mmol)を室温下で加え、20分間撹拌した。その後、
この反応液を800mlの蒸留水に注ぎ、さらに室温で1
時間撹拌した。生成した沈澱を吸引濾過後、濾液はベン
ゼン(2回)抽出し、水洗(2回)後、硫酸マグネシウ
ムで乾燥した。溶媒除去後真空乾燥することにより、目
的物(3e)及び(4e)の混合物を174mg(0.6
2mmol)得た(収率53%)。Example 11 Of 3-bromo-4,6,8-trimethyl-1,7-azulenequinone (3e) and 3-bromo-4,6,8-trimethyl-1,5-azulenequinone (4e) Manufacturing 4,6,8-Trimethylazulene 200mg in 50ml eggplant flask
(1.18 mmol) was taken and dissolved by heating in 40 ml of acetic acid. To this, 14 ml of distilled water was added and cooled to room temperature.
To this solution, 600 mg of bromine dissolved in 4 ml of acetic acid (3.7
(5 mmol) was added at room temperature and stirred for 20 minutes. afterwards,
The reaction solution was poured into 800 ml of distilled water and the mixture was further mixed at room temperature for 1 hour.
Stir for hours. The formed precipitate was filtered by suction, the filtrate was extracted with benzene (twice), washed with water (twice), and dried over magnesium sulfate. After removing the solvent, the residue was dried in vacuum to give 174 mg (0.6
2 mmol) was obtained (yield 53%).
【0062】[0062]
【化19】 [Chemical 19]
【0063】(3e)淡黄色針状晶;mp128℃分解,
(4e)淡黄色針状晶;mp160℃分解1H NMR(270MHz,CDC
l3)(混合物) δ:2.25(3H,d,J=1.5Hz,CH3),2.58(3H,s,CH3),2.69(3H,
s,CH3),6.73(1H,s,H-2),6.90(1H,q,J=1.5Hz,H-5). MS(70eV):m/z 280(M+,11%),278(M+,11%),252(11%),2
50(11%),171(100%),128(31%).(3e) pale yellow needle crystals; mp 128 ° C. decomposition,
(4e) Pale yellow needle crystals; mp 160 ℃ decomposition 1 H NMR (270MHz, CDC
l 3 ) (mixture) δ: 2.25 (3H, d, J = 1.5Hz, CH 3 ), 2.58 (3H, s, CH 3 ), 2.69 (3H,
s, CH 3 ), 6.73 (1H, s, H-2), 6.90 (1H, q, J = 1.5Hz, H-5) .MS (70eV): m / z 280 (M + , 11%), 278 (M + , 11%), 252 (11%), 2
50 (11%), 171 (100%), 128 (31%).
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C07C 221/00 225/20 7457−4H 319/14 323/22 7419−4H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical display location C07C 221/00 225/20 7457-4H 319/14 323/22 7419-4H
Claims (2)
〜6の数を示す。但し、1及び3位、5及び7位のう
ち、それぞれ少なくとも1箇所は水素原子である。)で
表わされるアズレン類を、酢酸中で、臭素と反応せしめ
ることを特徴とする下記一般式(1)又は(2) 【化2】 (式中、mは1〜2の整数を示し、R、nは前記と同義
である)で表わされるブロモアズレンキノン類の製造方
法。1. The following general formula (5): (In the formula, R represents an alkyl group having 1 to 4 carbon atoms, and n is 0
Indicates a number of ~ 6. However, at least one of the 1- and 3-positions, 5 and 7-positions is a hydrogen atom. ) The azulene represented by the formula (1) or (2) below is reacted with bromine in acetic acid. (In the formula, m represents an integer of 1 to 2, R and n have the same meanings as described above), and a method for producing bromoazulene quinones.
(1)又は(2)を求核試薬と反応せしめることを特徴
とする下記一般式(3)又は(4) 【化3】 (式中、Nuは炭素数1〜4のアルコキシ基若しくはア
ミノ基、炭素数1〜6のアルキル基、アルキルチオ基若
しくはアルキレンアミノ基、アニリノ基、トルイジノ
基、メルカプト基又は活性メチレン基を示し、R、n、
mは前記と同義である)で表わされるアズレンキノン類
の製造方法。2. A bromoazulene quinone (1) or (2) according to claim 1, which is reacted with a nucleophile, represented by the following general formula (3) or (4): (In the formula, Nu represents an alkoxy group or amino group having 1 to 4 carbon atoms, an alkyl group having 1 to 6 carbon atoms, an alkylthio group or an alkyleneamino group, an anilino group, a toluidino group, a mercapto group or an active methylene group, and R , N,
and m has the same meaning as defined above).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4515593A JPH06256249A (en) | 1993-03-05 | 1993-03-05 | Production of azulenequinone compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4515593A JPH06256249A (en) | 1993-03-05 | 1993-03-05 | Production of azulenequinone compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06256249A true JPH06256249A (en) | 1994-09-13 |
Family
ID=12711383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4515593A Pending JPH06256249A (en) | 1993-03-05 | 1993-03-05 | Production of azulenequinone compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06256249A (en) |
-
1993
- 1993-03-05 JP JP4515593A patent/JPH06256249A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0656839A (en) | Chelate complex and its manufacturing process | |
CA1325807C (en) | Tetracyclic antidepressants | |
Rozen et al. | A new approach toward the synthesis and chemistry of fluoroxy compounds | |
KR910001135B1 (en) | Process for the preparation of pyrazolo (1,5-a) pyridine derivatives | |
JPH06256249A (en) | Production of azulenequinone compound | |
JPS6183163A (en) | Antitumoral | |
JPH0710863B2 (en) | Novel derivative of 4-OH quinolinecarboxylic acid substituted at position 2 with an etherifiable or esterifiable dihydroxy group, a process for its preparation and its use as a medicament | |
CN110229056B (en) | Novel curcumin analogue and preparation method and application thereof | |
FR2503140A1 (en) | 4:Bi:phenyl 4:oxo 3:methylene butyric acid derivs. - for prevention and treatment of atherosclerosis | |
KR20230043128A (en) | Method for mass production of sodium taurodeoxycholate | |
JP2000510486A (en) | α-Tocopherol-4-aminobenzoic acid ester compound and method for producing the same | |
JPH08119898A (en) | Production of azulenequinones | |
CA2087741A1 (en) | Process for the production of 4,6-dialkoxypyrimidines | |
JP4701185B2 (en) | Method for producing camptothecin derivative | |
EP2540717A1 (en) | Lamivudine oxalate and preparation method thereof | |
CN118026929A (en) | Quinoline derivative containing diamine structure, and preparation method and application thereof | |
JPS5998091A (en) | Novel organosilicon compound, its preparation and antitumor agent containing said compound as active constituent | |
JPH05271271A (en) | 5-deazaflavin compound bonded with sialic acid | |
JPH06228103A (en) | New octahydroacridine derivative and its production | |
CA1105053A (en) | No translation available | |
CN113979976A (en) | Method for synthesizing nitrogen-containing phthalide compound at normal temperature | |
KR100474228B1 (en) | Separation method of paclitaxel | |
HU196964B (en) | Process for producing amino-nitro-pyridine derivatives | |
CA1274828A (en) | Triazolo(1,5-c) pyrimidines as bronchodilating agents | |
EP0168288A1 (en) | Aminomethyl-6-furo-[3,4-c]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |